Lmcg Investments LLC raised its holdings in The Cigna Group (NYSE:CI – Free Report) by 4.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 20,159 shares of the health services provider’s stock after buying an additional 768 shares during the quarter. Lmcg Investments LLC’s holdings in The Cigna Group were worth $6,664,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Silicon Valley Capital Partners grew its holdings in The Cigna Group by 100.0% in the 1st quarter. Silicon Valley Capital Partners now owns 70 shares of the health services provider’s stock valued at $25,000 after buying an additional 35 shares during the last quarter. Cedar Wealth Management LLC acquired a new stake in The Cigna Group in the 1st quarter valued at approximately $29,000. Raleigh Capital Management Inc. grew its holdings in The Cigna Group by 69.5% in the 4th quarter. Raleigh Capital Management Inc. now owns 100 shares of the health services provider’s stock valued at $30,000 after buying an additional 41 shares during the last quarter. TruNorth Capital Management LLC acquired a new stake in The Cigna Group in the 2nd quarter valued at approximately $33,000. Finally, Pineridge Advisors LLC acquired a new stake in shares of The Cigna Group during the 4th quarter worth approximately $37,000. Institutional investors and hedge funds own 86.99% of the company’s stock.
Insider Buying and Selling at The Cigna Group
In other news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares in the company, valued at $6,010,264.52. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, insider Brian C. Evanko sold 4,795 shares of the company’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $345.01, for a total transaction of $1,654,322.95. Following the transaction, the insider now owns 39,923 shares of the company’s stock, valued at $13,773,834.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the transaction, the director now directly owns 17,539 shares in the company, valued at approximately $6,010,264.52. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.
The Cigna Group Trading Up 0.6 %
The Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.42 by $0.30. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm had revenue of $60.52 billion during the quarter, compared to the consensus estimate of $58.30 billion. During the same quarter in the previous year, the company posted $6.13 EPS. The business’s revenue for the quarter was up 24.6% compared to the same quarter last year. Analysts predict that The Cigna Group will post 28.48 EPS for the current fiscal year.
The Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th will be given a $1.40 dividend. The ex-dividend date of this dividend is Wednesday, September 4th. This represents a $5.60 annualized dividend and a yield of 1.53%. The Cigna Group’s payout ratio is 45.98%.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the company. Stephens reissued an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a report on Friday, August 2nd. Baird R W raised The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Friday, August 2nd. Royal Bank of Canada reissued an “outperform” rating and set a $384.00 price objective on shares of The Cigna Group in a report on Monday, September 9th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a report on Monday. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $387.00.
Check Out Our Latest Stock Report on The Cigna Group
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories
- Five stocks we like better than The Cigna Group
- Buy P&G Now, Before It Sets A New All-Time High
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Technology Stocks Explained: Here’s What to Know About Tech
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 5 Oversold Stocks to Buy Right Now
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.